Atlas Trials

Pharmacologic Modulation of Hippocampal Activity in Psychosis

Clinical trial NCT04277936 · TERMINATED

Trial details

NCT number
NCT04277936
Sponsor
Vanderbilt University Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia; Psychosis
Start date
2020-05-11
Primary completion
2020-08-31
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.